CN120607506A - 方法和组合物 - Google Patents
方法和组合物Info
- Publication number
- CN120607506A CN120607506A CN202510576255.0A CN202510576255A CN120607506A CN 120607506 A CN120607506 A CN 120607506A CN 202510576255 A CN202510576255 A CN 202510576255A CN 120607506 A CN120607506 A CN 120607506A
- Authority
- CN
- China
- Prior art keywords
- dap
- amino acid
- alkyl
- acid
- suitably
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
- C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22069—SARS coronavirus main proteinase (3.4.22.69)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y601/00—Ligases forming carbon-oxygen bonds (6.1)
- C12Y601/01—Ligases forming aminoacyl-tRNA and related compounds (6.1.1)
- C12Y601/01026—Pyrrolysine-tRNAPyl ligase (6.1.1.26)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1817444.1 | 2018-10-26 | ||
| GBGB1817444.1A GB201817444D0 (en) | 2018-10-26 | 2018-10-26 | Methods and compositions |
| CN201980086289.4A CN113226375B (zh) | 2018-10-26 | 2019-10-24 | 方法和组合物 |
| PCT/GB2019/053023 WO2020084307A1 (en) | 2018-10-26 | 2019-10-24 | Methods and compositions |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980086289.4A Division CN113226375B (zh) | 2018-10-26 | 2019-10-24 | 方法和组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN120607506A true CN120607506A (zh) | 2025-09-09 |
Family
ID=64560429
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202510576255.0A Pending CN120607506A (zh) | 2018-10-26 | 2019-10-24 | 方法和组合物 |
| CN201980086289.4A Active CN113226375B (zh) | 2018-10-26 | 2019-10-24 | 方法和组合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980086289.4A Active CN113226375B (zh) | 2018-10-26 | 2019-10-24 | 方法和组合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12286657B2 (https=) |
| EP (1) | EP3870224A1 (https=) |
| JP (2) | JP7633156B2 (https=) |
| CN (2) | CN120607506A (https=) |
| AU (2) | AU2019369192B2 (https=) |
| CA (1) | CA3116567A1 (https=) |
| GB (1) | GB201817444D0 (https=) |
| WO (1) | WO2020084307A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014DN09922A (https=) | 2012-05-18 | 2015-08-14 | Medical Res Council | |
| GB201817444D0 (en) | 2018-10-26 | 2018-12-12 | Res & Innovation Uk | Methods and compositions |
| GB201906775D0 (en) | 2019-05-14 | 2019-06-26 | Res & Innovation Uk | Synthetic genome |
| CN114195665A (zh) * | 2021-12-14 | 2022-03-18 | 武汉世吉药业有限公司 | 一种高纯度ncaa的中和酸化工艺及设备 |
| EP4328308A1 (en) * | 2022-08-22 | 2024-02-28 | Technische Universität Berlin | Modified trna-synthetase for the incorporation of non-canonical amino acids |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5275566B2 (ja) | 2003-06-18 | 2013-08-28 | ザ スクリプス リサーチ インスティチュート | 反応性非天然アミノ酸遺伝コード付加 |
| WO2005019415A2 (en) | 2003-07-07 | 2005-03-03 | The Scripps Research Institute | Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| AU2004321117B2 (en) | 2003-12-18 | 2010-09-02 | The Scripps Research Institute | Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells |
| CA2580840A1 (en) | 2004-09-21 | 2006-03-30 | The Scripps Research Institute | In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
| EP1807515A4 (en) | 2004-10-27 | 2008-06-18 | Scripps Research Inst | Orthogonal translation components for the in vivo incorporation of unnatural amino acids |
| US8431558B2 (en) | 2004-11-01 | 2013-04-30 | The Regents Of The University Of California | Compositions and methods for modification of biomolecules |
| JP2007037445A (ja) | 2005-08-02 | 2007-02-15 | Institute Of Physical & Chemical Research | tRNA合成方法、核酸、アミノアシルtRNA合成方法及び非天然型アミノ酸組み込み蛋白質の製造方法 |
| US20090081669A1 (en) | 2006-02-01 | 2009-03-26 | Encode Bio, Inc. | Fluorescent Assays Using Orthogonal tRNA - Aminoacyl Synthetase Pairs |
| US20080096819A1 (en) | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
| US20090110662A1 (en) | 2007-04-30 | 2009-04-30 | Intezyne Technologies, Inc. | Modification of biological targeting groups for the treatment of cancer |
| JP5590649B2 (ja) | 2007-09-20 | 2014-09-17 | 独立行政法人理化学研究所 | 変異体ピロリジル−tRNA合成酵素及びこれを用いる非天然アミノ酸組み込みタンパク質の製造方法 |
| GB0721291D0 (en) | 2007-10-30 | 2007-12-12 | Medical Res Council | Methods and compositions |
| GB2470770A (en) | 2009-06-04 | 2010-12-08 | Medical Res Council | Incorporation of unnatural amino acids having an orthogonal functional group into polypeptides using orthogonal tRNA/tRNA synthetase pairs |
| GB0917242D0 (en) | 2009-10-01 | 2009-11-18 | Medical Res Council | Acetyl lysine incorporation with tRNA synthetase |
| GB0917240D0 (en) | 2009-10-01 | 2009-11-18 | Medical Res Council | Incorporation of methyl lysine into poiypeptide |
| US8697688B2 (en) | 2010-04-15 | 2014-04-15 | Seattle Genetics Inc. | Pyrrolobenzodiazepines used to treat proliferative diseases |
| DK2563753T6 (en) | 2010-04-27 | 2016-04-04 | Synaffix Bv | Fused cyclooctynforbindelser and their use in metal-free click-reactions |
| US20120077186A1 (en) | 2010-05-07 | 2012-03-29 | Oregon Health & Science University | Use of cysteine-derived suppressor trnas for non-native amino acid incorporation |
| WO2011156686A2 (en) | 2010-06-11 | 2011-12-15 | The Regents Of The University Of Colorado, A Body Corporate | Method for synthesizing a cyclic multivalent peptide using a thiol-mediated reaction |
| DK2670767T3 (en) | 2011-02-03 | 2018-03-26 | European Molecular Biology Laboratory | Non-naturally occurring amino acids comprising a cyclooctynyl or transcyclooctynyl analog group and uses thereof |
| GB201110815D0 (en) | 2011-06-24 | 2011-08-10 | Medical Res Council | Incorporation of subtituted lysines into polypeptides |
| WO2013036748A1 (en) | 2011-09-09 | 2013-03-14 | Berry, Lana, L. | Bicyclo[6.1.0]non-4-yne reagents for chemical modification of oligonucleotides |
| GB201201100D0 (en) | 2012-01-20 | 2012-03-07 | Medical Res Council | Polypeptides and methods |
| IN2014DN09922A (https=) | 2012-05-18 | 2015-08-14 | Medical Res Council | |
| HRP20220455T1 (hr) * | 2012-08-31 | 2022-05-27 | Sutro Biopharma, Inc. | Modificirane aminokiseline koje sadrže azid grupu |
| SG10201702387YA (en) | 2012-09-24 | 2017-04-27 | Medimmune Ltd | Cell lines |
| EP3087088B1 (en) * | 2013-12-23 | 2022-05-25 | University Of Rochester | Methods and compositions for ribosomal synthesis of macrocyclic peptides |
| GB2528227A (en) | 2014-03-14 | 2016-01-20 | Medical Res Council | Cyclopropene amino acids and methods |
| GB201419109D0 (en) | 2014-10-27 | 2014-12-10 | Medical Res Council | Incorporation of unnatural amino acids into proteins |
| GB201613135D0 (en) | 2016-07-29 | 2016-09-14 | Medical Res Council | Genome editing |
| WO2019028419A1 (en) * | 2017-08-03 | 2019-02-07 | Synthorx, Inc. | CYTOKINE CONJUGATES FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES |
| GB201817444D0 (en) | 2018-10-26 | 2018-12-12 | Res & Innovation Uk | Methods and compositions |
| GB201906775D0 (en) | 2019-05-14 | 2019-06-26 | Res & Innovation Uk | Synthetic genome |
| CN117881779A (zh) | 2021-05-28 | 2024-04-12 | 英国研究与创新署 | 微生物及其用途 |
-
2018
- 2018-10-26 GB GBGB1817444.1A patent/GB201817444D0/en not_active Ceased
-
2019
- 2019-10-24 AU AU2019369192A patent/AU2019369192B2/en active Active
- 2019-10-24 JP JP2021521504A patent/JP7633156B2/ja active Active
- 2019-10-24 EP EP19806312.5A patent/EP3870224A1/en active Pending
- 2019-10-24 CA CA3116567A patent/CA3116567A1/en active Pending
- 2019-10-24 CN CN202510576255.0A patent/CN120607506A/zh active Pending
- 2019-10-24 US US17/288,798 patent/US12286657B2/en active Active
- 2019-10-24 CN CN201980086289.4A patent/CN113226375B/zh active Active
- 2019-10-24 WO PCT/GB2019/053023 patent/WO2020084307A1/en not_active Ceased
-
2024
- 2024-10-23 JP JP2024186312A patent/JP2025023942A/ja active Pending
-
2025
- 2025-03-21 US US19/086,998 patent/US20250283066A1/en active Pending
- 2025-07-18 AU AU2025205622A patent/AU2025205622A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020084307A1 (en) | 2020-04-30 |
| AU2025205622A1 (en) | 2025-08-07 |
| CA3116567A1 (en) | 2020-04-30 |
| US20220010296A1 (en) | 2022-01-13 |
| CN113226375A (zh) | 2021-08-06 |
| JP2025023942A (ja) | 2025-02-19 |
| AU2019369192B2 (en) | 2025-08-14 |
| AU2019369192A1 (en) | 2021-05-13 |
| EP3870224A1 (en) | 2021-09-01 |
| JP2022505464A (ja) | 2022-01-14 |
| US20250283066A1 (en) | 2025-09-11 |
| US12286657B2 (en) | 2025-04-29 |
| CN113226375B (zh) | 2025-05-13 |
| JP7633156B2 (ja) | 2025-02-19 |
| GB201817444D0 (en) | 2018-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113226375B (zh) | 方法和组合物 | |
| Plaza et al. | Mirabamides A–D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion | |
| Wu et al. | Cadasides, calcium-dependent acidic lipopeptides from the soil metagenome that are active against multidrug-resistant bacteria | |
| US9260484B2 (en) | Small molecule composite surfaces as inhibitors of protein-protein interactions | |
| Brouwer et al. | Peptido sulfonyl fluorides as new powerful proteasome inhibitors | |
| Sikandar et al. | Total in vitro biosynthesis of the thioamitide thioholgamide and investigation of the pathway | |
| US8063181B2 (en) | Method for the production of cyclic molecules | |
| US9376700B2 (en) | Methods of modifying N-termini of a peptide or protein using transferases | |
| KR20250051803A (ko) | 비모이어티 의존적 티오에테르 설치 도구로서의 papb | |
| Konno et al. | Peptide mixed phosphonates for covalent complex formation with thioesterases in nonribosomal peptide synthetases | |
| Ahn | Mechanistic studies of PLP-independent racemases | |
| Weckenmann et al. | Enantioselective Synthesis of D‐α‐(Uracil‐5‐yl) glycine Derivatives and Their Racemization‐Free Incorporation into a Model Peptide | |
| Shmygarev et al. | Amicoumacin-Based Prodrug Development Approach | |
| Wheadon | MECHANISM OF CONDENSATION DOMAIN CATALYZED β-LACTAM FORMATION IN A NONRIBOSOMAL PEPTIDE SYNTHETASE: EVOLUTIONARY ORIGIN AND INSPIRED CHEMICAL TOOLS | |
| Zhao et al. | Nobachelins, new siderophores from Nocardiopsis baichengensis protecting Caenorhabditis elegans from Pseudomonas aeruginosa infection | |
| Alexander | Selective Inhibition of Virulence Factors in the Human Microbiota | |
| Beech | Examining and exploiting docking domain-mediated carrier protein recognition in aeruginosin biosynthesis | |
| Suchanová | Návrh a syntéza inhibitorů DDl založených na isothiazolidinonovém jádře | |
| Wever | Studies towards the chemoenzymatic syntheses of thiopeptides and thiomarinol and visible light catalyzed O-glycosylation of thioglycosides | |
| Schramma et al. | Investigations into the Mechanism and Substrate Scope of AgaB and the Chemo-Enzymatic Total Synthesis of Streptide Natural Products | |
| Just Baringo | Thiopeptides: Synthesis and Structure-Activity Relationship Studies | |
| Courtemanche | Bioactive Cyclic Peptides and Chemical Probes | |
| Wallock-Richards | Natural products: biosynthesis, antimicrobial properties and protein targets | |
| Nangreave | Novel Strategies for Producing Proteins with Non-proteinogenic Amino Acids | |
| Hoffmann | Mass spectrometry in natural product research: deciphering microbial biosyntheses and contributions to a novel screening approach |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |